Lambert-Eaton Myasthenic Syndrome in Lung Cancer

Table 1

Demographics of 14 LEMS patients with lung cancer.

Characteristic	No. of patients (%)
Total number	14
Male/female	9/5
Age (years old)	67.1 ± 8.4
Smoking history	10/14
SCLC	13 (92.9%)
Adenocarcinoma	1 (7.1%)
Stage III-IV at diagnosis	9 (64.3%)
Performance status score 0-1	9 (64.3%)
Karnofsky performance score ＞70	9 (64.3%)
Misdiagnosis	12 (85.7%)
Concurrent immunological disorder	3 (21.4%)
Median time between diagnosis of LEMS and detection of the SCLC (months)	5.2 ± 5.5
Median interval between onset of symptoms and completely diagnosis of lung cancer coexisting with LEMS (months)	11.9 ± 7.0